Perspectives for personalized therapy for patients with multidrug‐resistant tuberculosis

Overview of attention for article published in Journal of Internal Medicine, July 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

policy: 2 policy sources

twitter: 5 X users

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 89 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 4 policy documents that reference this research output.

Georgia Hepatitis Elimination Program progress report 2020-2021

Cited by Centers for Disease Control and Prevention (CDC) on 20 Apr 2022

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.

Туберкулез с множественной лекарственной устойчивостью возбудителя у детей и подростков в Европейском регионе ВО: Экспертное мнение

Cited by World Health Organization on 27 Apr 2020

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline

Cited by Centers for Disease Control and Prevention (CDC) on 15 Nov 2019

Multidrug-resistant tuberculosis in children and adolescents in the WHO European Region: expert opinion

Cited by World Health Organization on 18 Oct 2019

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.